123. 124. Crile, G. Jr. Changing end results in patients with papillary carcinoma of the thyroid. Surg. Gynecol. Obstet. 132: 460-8 (1971). Hazard, J.B., Crile, G. Jr., and Dempsey, W.S. Nonencapsulated scler- 126. osing tumors of the thyroid. J. Clin. Endocrinol. 9: 1215 (1949). Franssila, K.0. Prognosis in thyroid carcinoma. Cancer 36: 1138-46 (1975). Hazard, J.B. Small papillary carcinoma of the thyroid: A study with 127. Invest. 9: 86-97 (1960). Klinck, G.H. and Winship, T. 125. 128. special reference to so-called nonencapsulated sclerosing tumor. roid. Cancer 8: 701 (1955). Williams, E.D. 757-9 (1975). Lab. Occult sclerosing carcinoma of the thy- The pathology of thyroid malignancy. . Br. J. Surg. 62: 130. Sampson, R.J., Oka, H., Key, C.R., Buncher, C.R., and Lijima, S. Metastases from occult thyroid carcinoma: An autopsy study from Hiroshima and Nagasaki, Japan. Cancer 25: 803-11 (1970). Fukunaga, F.H. and Yatani, R. Geographic pathology of occult thyroid 131. Sawin, C.T. and Hershman, J.M. 129. carcinomas. Cancer 36: 1095-9 (1975). The TSH response to thyrotropin- releasing hormone (TRH) in young adult men: Intra-individual variation and relation to basal serum TSH and thyroid hormones. 132. J. Clin. Endocrinol. Metab. 46: 217 (1978). Thein-Wai, W. and Larsen, P.R. Effects of weekly thyroxine administra- tion on serum thyroxine and 3,5,3'-triiodothyronine, thyrotropin and thyrotropin response to thyrotropin-releasing hormone. Endocrinol. Metab. 50: 660 (1980). J. Clin. 133. Tunbridge, 134, spectrum of thyroid disease in a community: The Wickham survey. Clin. Endocrinol. 7: 481 (1977). Van Middlesworth, L. Factors influencing the thyroid uptake of iodine W.M.G., Evered, D.C., isotopes from nuclear fission: 135. 136. Hall, R., Appleton, D., Brewis, M., Clark, F., Grimley Evans, J., Young, E., Bird, T., and Smith, P.A. (1963). Evans, T.C., A review. Health Phys. 9: ~ 1197-1211 Kretzchmar, R.H., Hodges, R.E., and Song, C.W. uptake studies of the human fetal thyroid. (1967). The Radioiodine J. Nucl. Med. 8: 157-60 Hodges, R.E., Evans, T.C., Bradbury, J.T., and Keettel, W.C. mulation of radioactive iodine by human fetal thyroids. Endocrinol. Metab. 15: 661-7 (1955). The accu- J. Clin. 137. 138. Mays, C.W. (University of Utah}, Personal communication, 1974. Russel, K.P., Rose, H., and Starr, P. The effects of radioactive iodine 139. Fisher, W.D., Voorhess, M.L., and Gardner, L.I. in maternal and fetal thyroid function during pregnancy. Obstet. 104: 560-4 (1957). Congenital hypothyroid- ism in infant following maternal qi31 therapy, with a review of hazards of environmental radioisotope contamination. 140. Surg. Gynecol. (1963). Hamill, G.C., Jarman, J.A., and Wynne, M.D. J. Pediat. 62: 132-46 Fetal effects of radio- active iodine therapy in a pregnant woman with thyroid cancer. Obstet. Gynecol. 81: 1018-23 (1961). - 96 - Am. J.